In CKD patients, however, variability in the metabolism of components like hemoglobin has notably been linked to (i) changes in the lifespan of red blood cells, (ii) the prescription or not of erythropoietin, and (iii) blood loss during dialysis. The gene discussed is EPO; the disease is chronic kidney disease.